STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
Phase 2
Recruiting
- Conditions
- Triple Negative Breast CancerBreast Cancer
- Interventions
- First Posted Date
- 2021-02-24
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 25
- Registration Number
- NCT04768426
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Yoga for Youth With IBD: a Pilot Feasibility Study
Not Applicable
Completed
- Conditions
- YogaInflammatory Bowel DiseasesUlcerative ColitisAdolescentsCrohn Disease
- First Posted Date
- 2021-02-17
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 9
- Registration Number
- NCT04757935
- Locations
- 🇺🇸
Lucile Packard Children's Hospital, Palo Alto, California, United States
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
Phase 2
Recruiting
- Conditions
- Advanced Breast CancerBreast Cancer
- Interventions
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT04756765
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery
Phase 4
Completed
- Conditions
- Chronic SinusitisNasal ObstructionTurbinate; Hypertrophy Mucous MembraneDeviated Nasal Septum - CongenitalDeviated Nasal Septum Acquired
- Interventions
- Drug: Tranexamic Acid 1,000 Mg/10 mL (100 Mg/mL) INTRAVEN VIAL (ML)
- First Posted Date
- 2021-02-15
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 40
- Registration Number
- NCT04754230
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Leveraging Clinic to Promote Literacy in Young Children
Not Applicable
Completed
- Conditions
- Literacy
- Interventions
- Other: Tips By Text Messages
- First Posted Date
- 2021-02-12
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 381
- Registration Number
- NCT04752943
- Locations
- 🇺🇸
Valley Medical Center, San Jose, California, United States
Rapid Acting Transcranial Magnetic Stimulation
Not Applicable
Recruiting
- Conditions
- Treatment Resistant Depression
- Interventions
- Device: Sham TBS-DLPFCDevice: Active TBS-DLPFC
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 100
- Registration Number
- NCT04739969
- Locations
- 🇺🇸
Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Stanford, California, United States
A Lead-in Study Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism
Not Applicable
Completed
- Conditions
- AutismAutism Spectrum Disorder
- Interventions
- Device: GuessWhat Mobile App
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 555
- Registration Number
- NCT04739982
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Microbiome Individuality and Stability Over Time
Not Applicable
Completed
- Conditions
- Diet
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 21
- Registration Number
- NCT04740684
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Remote Monitoring of Respiratory Health
Not Applicable
Terminated
- Conditions
- Chronic Respiratory DiseaseCopdAsthma
- Interventions
- Device: Mobile Monitoring Device
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 20
- Registration Number
- NCT04739943
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome
Phase 1
Withdrawn
- Conditions
- Covid19Acute Respiratory Distress Syndrome
- Interventions
- Biological: T regulatory cells
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- Stanford University
- Registration Number
- NCT04737161
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
© Copyright 2025. All Rights Reserved by MedPath